12 Best Investment Tracking Notebooks for 2026

I compared 12 investment tracking notebooks for structure, paper quality, and long-term value. See which logbooks suit traders, dividend investors, and beginners.

CAR Investors Have Opportunity To Lead Avis Budget Group, Inc. Securities Fraud Lawsuit Against Pentwater Capital Management LP

Investors in CAR may pursue a securities fraud lawsuit against Avis Budget Group, with Pentwater Capital Management implicated. Details are still emerging.

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of LEQEMBI® (Lecanemab) For Early Alzheimer’s Disease

Canada’s drug regulator issues final positive recommendation to support public reimbursement of Leqembi® (lecanemab) for early Alzheimer’s disease, marking a key policy shift.

Baidu Announces Dual-Primary Listing On The Main Board Of The Stock Exchange Of Hong Kong Limited

Baidu has announced a dual-primary listing on the Main Board of the Hong Kong Stock Exchange, marking a strategic move for the company.

Ausschreibung Tenderverfahren – Aufstockung Der Bundesobligationen Serie 194

Die Bundesbank hat ein Tenderverfahren zur Aufstockung der Bundesobligationen Serie 194 veröffentlicht. Details sind noch unbestätigt, doch die Maßnahme könnte Auswirkungen auf den Markt haben.

Free Cash Flow Yield Screens Work Best When You Filter Out This Trap

Ineffective filtering of accounting irregularities can lead investors astray; learn how to identify genuine undervalued companies through better cash flow analysis.

Isabel Schnabel: Central Banks On-chain

ECB’s Isabel Schnabel signals growing interest in central banks adopting on-chain technologies amid rising coverage and speculation.

Niutech Signs Agreement With Global Energy Leader For SAF Plant

Niutech has signed an agreement with a major energy company to develop a plastic waste pyrolysis line for sustainable aviation fuel production.

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China

HUTCHMED announces significant progression-free survival gains in SANOVO trial combining ORPATHYS® and TAGRISSO® for MET-overexpressing EGFR-mutant lung cancer in China.

Global Times: How Fresh Dynamics, Fierce Competition Reshape China’s Auto Market

Analysis of how recent shifts and intense rivalry are reshaping China’s automotive industry, driven by emerging players and evolving consumer preferences.